Skip to content

GMP Guideline

Trusted GMP guidance written for real-world professionals

Tag: pharmaceutical manufacturing

  • Home
  • pharmaceutical manufacturing
  • Page 113
GMP by Industry

Documentation Control Issues in Medical Device GMP (21 CFR 820)

Documentation Control Issues in Medical Device GMP (21 CFR 820) Understanding Documentation Control Challenges within…
Validation and Qualification

Incomplete Traceability Across IQ OQ and PQ Stages

Incomplete Traceability Across IQ OQ and PQ Stages Challenges of Incomplete Traceability in Equipment Qualification…
Pharmaceutical GMP

Documentation Control Issues in Injectable Products GMP

Documentation Control Issues in Injectable Products GMP Addressing Documentation Control Challenges in GMP for Injectable…
Quality Assurance under GMP

Integration of Change Control with CAPA Systems

Integration of Change Control with CAPA Systems Harmonizing Change Control and CAPA Systems in the…
GMP by Industry

Management Oversight Weaknesses in Medical Device GMP (21 CFR 820)

Management Oversight Weaknesses in Medical Device GMP (21 CFR 820) Identifying Management Oversight Weaknesses in…
Validation and Qualification

Regulatory Risks from Inadequate Acceptance Criteria

Regulatory Risks from Inadequate Acceptance Criteria Understanding Regulatory Risks from Insufficient Acceptance Criteria in Equipment…
Pharmaceutical GMP

Management Oversight Weaknesses in Injectable Products GMP

Management Oversight Weaknesses in Injectable Products GMP Addressing Management Oversight Issues in the GMP of…
GMP by Industry

CAPA Gaps Following Medical Device GMP (21 CFR 820) Observations

CAPA Gaps Following Medical Device GMP (21 CFR 820) Observations Identifying CAPA Deficiencies in Medical…
Validation and Qualification

Audit Findings Related to Qualification Deficiencies

Audit Findings Related to Qualification Deficiencies Common Audit Findings Concerning Equipment Qualification Shortcomings In the…
Pharmaceutical GMP

CAPA Gaps Following Injectable Products GMP Observations

CAPA Gaps Following Injectable Products GMP Observations Identifying CAPA Gaps in Response to Injectable Products…

Posts pagination

Previous 1 … 112 113 114 … 179 Next

Recent Posts

  • Weak Integration of Laboratory Practices with Quality Systems
  • Regulatory Risks from Weak QA Governance Systems
  • Documentation Gaps in GLP and GMP Records
  • Audit Observations Related to QA Oversight Failures
  • Failure to Align Lab Practices with Regulatory Expectations

Categories

  • Documentation and Data Integrity
  • Global GMP Guidelines
  • GMP Audits and Inspections
  • GMP Basics
  • GMP by Industry
  • Pharmaceutical GMP
  • Quality Assurance under GMP
  • Quality Control under GMP
  • SOPs
  • Training and Careers
  • Uncategorized
  • Validation and Qualification
Copyright © 2026 GMP Guideline Theme: Timely News By Artify Themes.